The interdisciplinary team's approach to lupus nephritis

被引:7
作者
Crane, M
Pucino, F
Sebring, N
Irby, D
Perry, M
Mattiko, M
Yarboro, C
机构
[1] NIAMSD, Arthrit & Rheumatism Branch, NIH, Bethesda, MD 20892 USA
[2] NIH, Warren Grant Magnuson Clin Ctr, Dept Clin Immunol & Pharm, Bethesda, MD 20892 USA
[3] NIH, Warren Grant Magnuson Clin Ctr, Dept Nutr, Bethesda, MD 20892 USA
[4] NIH, Warren Grant Magnuson Clin Ctr, Dept Social Work, Bethesda, MD 20892 USA
[5] NIH, Warren Grant Magnuson Clin Ctr, Dept Rehabil Med, Bethesda, MD 20892 USA
关键词
chronic disease; interdisciplinary team; lupus nephritis;
D O I
10.1191/096120398678920820
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The interdisciplinary team approach in assessment and treatment of patients with chronic disease in general and lupus nephritis in particular provides a global format for identifying the multiple problem areas that retard or prevent optimal patient functioning. These areas include the physical, emotional, economic, psychosocial, and functional. Benefits to the individual patient include a thorough multifaceted assessment by professionals who have the benefit of peer collaboration and validation. This increases the likelihood that the whole patient is considered, not just the problem of nephritis. For example, how does the patient and her or his family cope with the impact of such a disease and how, in turn, do the coping abilities of the patient and family affect the disease. The interdisciplinary team also assesses how the treatment strategies for each problem area influence each other. Finally, the interdisciplinary team serves as a positive role model for effective collaboration among health professionals and for students in their respective disciplines.
引用
收藏
页码:660 / 665
页数:6
相关论文
共 19 条
  • [1] BENNETT WM, 1994, DRUG PRESCRIBING REN
  • [2] Benson JA, 1997, NURS HEALTH CARE PER, V18, P285
  • [3] OPTIMAL CALCIUM INTAKE
    BILEZIKIAN, JP
    BAILEY, L
    ELMER, PJ
    FAVUS, MJ
    GO, VLW
    GOLDRING, SR
    HOLT, LH
    INSOGNA, KL
    KRIMGOLD, B
    MALLETTE, LE
    SHAPIRO, JR
    STJEOR, ST
    STERN, PH
    TILLEY, BC
    YAMAMOTO, ME
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24): : 1942 - 1948
  • [4] BOTO J, 1995, J AM DIET ASSOC, V95, P898
  • [5] Campbell L J, 1987, Clin Geriatr Med, V3, P99
  • [6] ALENDRONATE TREATMENT OF THE POSTMENOPAUSAL OSTEOPOROTIC WOMAN - EFFECT OF MULTIPLE DOSAGES ON BONE MASS AND BONE REMODELING
    CHESTNUT, CH
    MCCLUNG, MR
    ENSRUD, KE
    BELL, NH
    GENANT, HK
    HARRIS, ST
    SINGER, FR
    STOCK, JL
    YOOD, RA
    DELMAS, PD
    KHER, U
    PRYORTILLOTSON, S
    SANTORA, AC
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 99 (02) : 144 - 152
  • [7] CSAKO G, 1997, ACR 61 NAT SCI M 199
  • [8] ACCURACY OF ANTICARDIOLIPIN ANTIBODIES IN IDENTIFYING A HISTORY OF THROMBOSIS AMONG PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    ESCALANTE, A
    BREY, RL
    MITCHELL, BD
    DREINER, U
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 98 (06) : 559 - 565
  • [9] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [10] Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis - A randomized, controlled trial
    Gourley, MF
    Austin, HA
    Scott, D
    Yarboro, CH
    Vaughn, EM
    Muir, J
    Boumpas, DT
    Klippel, JH
    Balow, JE
    Steinberg, AD
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 549 - +